Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China

Lucette A Cysique, Scott L Letendre, Christopher Ake, Hua Jin, Donald R Franklin, Saurabh Gupta, Chuan Shi, Xin Yu, Zunyou Wu, Ian S Abramson, Igor Grant, Robert K Heaton, HIV Neurobehavioral Research Center group, Igor Grant, J Hampton Atkinson, Ronald J Ellis, J Allen McCutchan, Thomas D Marcotte, Braden R Hale, Ronald J Ellis, J Allen McCutchan, Scott Letendre, Edmund Capparelli, Rachel Schrier, Robert K Heaton, Mariana Cherner, Steven Paul Woods, Terry Jernigan, Christine Fennema-Notestine, L Sarah, Archibald, John Hesselink, Jacopo Annese, Michael J Taylor, Eliezer Masliah, Ian Everall, Cristian Achim, Douglas Richman, David M Smith, J Allen McCutchan, Ian Everall, Stuart Lipton, J Allen McCutchan, J Hampton Atkinson, Ronald J Ellis, Scott Letendre, J Hampton Atkinson, Rodney von Jaeger, Anthony C Gamst, Clint Cushman, Daniel R Masys, Ian Abramson, Christopher Ake, Reena Deutsch, Florin Vaida, Lucette A Cysique, Scott L Letendre, Christopher Ake, Hua Jin, Donald R Franklin, Saurabh Gupta, Chuan Shi, Xin Yu, Zunyou Wu, Ian S Abramson, Igor Grant, Robert K Heaton, HIV Neurobehavioral Research Center group, Igor Grant, J Hampton Atkinson, Ronald J Ellis, J Allen McCutchan, Thomas D Marcotte, Braden R Hale, Ronald J Ellis, J Allen McCutchan, Scott Letendre, Edmund Capparelli, Rachel Schrier, Robert K Heaton, Mariana Cherner, Steven Paul Woods, Terry Jernigan, Christine Fennema-Notestine, L Sarah, Archibald, John Hesselink, Jacopo Annese, Michael J Taylor, Eliezer Masliah, Ian Everall, Cristian Achim, Douglas Richman, David M Smith, J Allen McCutchan, Ian Everall, Stuart Lipton, J Allen McCutchan, J Hampton Atkinson, Ronald J Ellis, Scott Letendre, J Hampton Atkinson, Rodney von Jaeger, Anthony C Gamst, Clint Cushman, Daniel R Masys, Ian Abramson, Christopher Ake, Reena Deutsch, Florin Vaida

Abstract

Objective: To quantify and characterize the nature of cognitive change over 1 year in a cohort of HIV-positive former plasma donors in rural China.

Design: The present study is an observational cohort study.

Methods: One hundred and ninety-two HIV-positive and 101 demographically comparable HIV-negative individuals, all former plasma donors, who lived in a rural part of China, received comprehensive medical and neuropsychological examinations. At study entry, 56% of HIV-positive group was on combination antiretroviral treatment and 60.9% at follow-up. Multiple regression change score approach was used with the HIV-negative sample to develop norms for change that would be then applied to the HIV-positive participants. Follow-up test scores adjusted for the control group practice effect.

Results: Fifty-three HIV-positive individuals (27%) developed significant cognitive decline as compared with five (5%) HIV-negative individuals. Cognitive decline was predicted at baseline by AIDS status, lower nadir CD4, and worse processing speed; at follow-up, it was associated with lower current CD4 cell count and failure of viral suppression on combination antiretroviral treatment. Neuropsychological decline also was associated with decreased independence in activities of daily living. Using neuropsychological impairment scores that were corrected for 'practice' on repeated testing, we found that among the decliners, 41.5% (N = 22) had incident impairment, whereas 38% (N = 20) declined within the impaired range and another 20.7% (N = 11) declined within the normal range.

Conclusion: The present study demonstrates that despite ongoing combination antiretroviral treatment, cognitive decline in HIV-positive people is common over a 1-year follow-up. Regression-based norms for change on western neuropsychological tests can be used to detect disease-related cognitive decline in a developing country.

Figures

Figure 1. Percentage of NP change as…
Figure 1. Percentage of NP change as defined by the summary regression change score in the HIV+ and HIV− samples
% participants who were classified as being stable or decliners on the summary regression change score (sRCS; 95% confidence interval, 1-tailed).

Source: PubMed

3
Tilaa